Speaking Faculty (Tentative)
Aris Persidis, Ph.D.President, Biovista
Clare Thibodeaux, Ph.D.Vice President, Scientific Affairs, Cures Within Reach
Dr. Bruce BloomFounder, Cures Within Reach, Chief Collaboration Officer, Healx
Laura Kleiman, Ph.D.Founder & CEO, Reboot Rx
Matthew Fedowitz, JDShareholder, Buchanan Ingersoll & Rooney
John SemanChief Executive Officer, Revitale Pharma
Eyal Barash, JDFounder, Barash Law
James Doyle, Ph.D.Co-Founder and CEO, Modelis
Andrew Reaume, Ph.D., MBAPresident & CEO, Co-Founder, Melior Discovery
Stephen CaseyFounder & CEO, The 505(b)(2) Platform
Michael DerbyManaging Partner, TardiMed Sciences
Heather Mortiboys, Ph.D.Senior Lecturer, Associate Professor, University of Sheffield
David H. Crean, Ph.D., MBAPresident & CEO, Coast Bioventures
Malina Bakowski, Ph.D.Principal Investigator, Calibr at Scripps Research
Richard Wyse, MDDirector of Research & Development, Cure Parkinson's Trust
Sven Jacobson, MBACEO, Woolsey Pharmaceuticals, Co-Founder & CEO, Martin Pharmaceuticals
Sundeep Dugar, Ph.D.President & Chief Executive Officer, Aayam Therapeutics
Yossef Av-Gay, Ph.D.Professor, Departments of Medicine and Microbiology and Immunology, University of British Columbia
Santiago Ramon-Garcia, Ph.D.ARAID Investigator, Research and Development Agency of Aragon (ARAID) Foundation
Yi Rang Kim, MD, Ph.D.Yi Rang Kim, MD, Ph.D., ONCOCROSS
Tomas Babak, Ph.D.Chief Executive Officer, Leapfrog Bio